Biol stock forecast.

BIOLASE Stock Forecast 23 Nov. Presumably, on 11/23/2023, the price of shares will be in the range of $1.42 - $1.48. A $0.07 range width can provide 4.64% volatility. The weighted average price of this range is at $1.44, which is $0.00 lower than the previous day's weighted average price.

Biol stock forecast. Things To Know About Biol stock forecast.

BIOLASE Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 1.19. Negative dynamics for BIOLASE shares will prevail with possible volatility of 4.961%. Pessimistic target level: 1.17. Optimistic target level: 1.23.Oct 26, 2021 · For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72. The average BIOLASE stock forecast 2031 represents a 66.26% increase from the last price of $1.14999997615814. For BIOLASE stock forecast for 2033 (10 year ... DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66.With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.

Nasdaq | BIOL U.S.: Nasdaq Biolase Inc. Watch list Set a price target alert After Hours Last Updated: Nov 24, 2023 4:47 p.m. EST Delayed quote $ 1.2400 0.00 0.00% After Hours …CEO. Website. 1984. 190. John Beaver. https://www.biolase.com. BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists ...

BIOL Stock Analysis Overview What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of …BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company also offers consumable products, teeth whitening kits, and earnings reports.

BIOL BIOLASE (BIOL) Stock Forecast for 2023 – 2026. Sell or Buy? Updated: November 25, 2023 (09:30) Sector: Healthcare The share price of BIOLASE, …BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ... Looking at the chart of Biolase Inc. (BIOL Stock Forecast), we can see a starkly different trend in comparison to the AMPE stock chart. Sure, this year has been relatively flat. But pull out a 2-year chart and you’ll see that BIOL stock has been in a perpetual downtrend since last March.Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

The average price target for Biolase Inc's stock set by recognized analysts recently is $2.00, which would result in a potential upside of approximately 61.29% if it …

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Unlock tomorrow's (BIOL) stock trends with our detailed analysis. Get insights on BIOLASE, Inc.'s performance, backed by data-driven predictions for informed investment.Jul 26, 2023 · COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's stockholders granted the Board of Directors the discretion to effect a ... For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72. The average BIOLASE stock forecast 2031 represents a 66.26% increase from the last price of $1.14999997615814. For BIOLASE stock forecast for 2033 (10 year ...How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997. Find the latest Verde Bio Holdings, Inc. (VBHI) stock quote, history, news and other vital information to help you with your stock trading and investing.See the latest Biolase Inc stock price (BIOL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 27, 2023 · The Biolase stock price fell by -6.45% on the last day (Monday, 27th Nov 2023) from $1.24 to $1.16. During the last trading day the stock fluctuated 10.00% from a day low at $1.10 to a day high of $1.21. The price has been going up and down for this period, and there has been a 0.87% gain for the last 2 weeks. Find the latest Adicet Bio, Inc. (ACET) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...BIOL's price to book (P/B) is 81% more than its last 4 quarters average of 2.0 but 38% less than its 5-year quarterly average of 5.8 The stock's price to sales (P/S) is 97% less than its 5-year quarterly average of 1.0 and 70% less than its last 4 quarters average of 0.1Precigen. Precigen is a synthetic biology company focused on developing the next generation of gene and cell therapies targeting immuno-oncology, autoimmune disorders, and infectious diseases. The ...Zymergen, which describes itself as a “biofacturing company using biology to reimagine the world,” plunged 68% in extended trading on Tuesday to $11.07, down from its IPO price of $31. The ...Find the latest Twist Bioscience Corporation (TWST) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...

The average Biora Therapeutics stock price prediction forecasts a potential upside of 3,932.26% from the current BIOR share price of $1.24. What is BIOR's forecast return on equity (ROE) for 2023-2026? (NASDAQ: BIOR) forecast ROE is …

Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business.The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...Find the latest BridgeBio Pharma, Inc. (BBIO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Nov 29, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. Learn more on BIOL's analyst rating history. The Biolase Inc (BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1,639% increase from the current price of $1.2506. The highest analyst price target is $42.41, and the lowest is $1.0934.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Nov 3, 2023 · BIOLASE Stock Forecast 23 Nov. Presumably, on 11/23/2023, the price of shares will be in the range of $1.42 - $1.48. A $0.07 range width can provide 4.64% volatility. The weighted average price of this range is at $1.44, which is $0.00 lower than the previous day's weighted average price. 0.06%. $36.28B. bioMerieux S.A. -0.33%. €11.49B. BIO | Complete Bio-Rad Laboratories Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

The current average BIOL price target, as estimated by these analysts, is $0.00. The predictions for the future BIOL stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for BIOL.

Synthetic biology can solve our most pressing problems, and these three stocks are already doing it. By John Blankenhorn, InvestorPlace Contributor Aug 25, 2023, 5:11 pm EST. Synthetic biology ...

Maybe one or two of three stocks will fail, but those small losses are irrelevant if and when the third stock has a 1,000% return. Here's why Ontrak ( OTRK 3.67%) , Nano-X Imaging ( NNOX 14.20% ...Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business.Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.According to . 1 Wall Street analyst that have issued a 1 year BIOL price target, the average BIOL price target is $40.00, with the highest BIOL stock price forecast at $40.00 and the lowest BIOL stock price forecast at $40.00. Adecoagro ( NYSE:AGRO ) $1.1 billion. A South American farming operation, including production of wheat. 1. Deere and Co. Deere and Co., better known as John Deere, is one of the most iconic U.S ...MarketWatch IBD Sign In Biolase Inc. BIOL (U.S.: Nasdaq) Overview News Biolase Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-158.42...Adecoagro ( NYSE:AGRO ) $1.1 billion. A South American farming operation, including production of wheat. 1. Deere and Co. Deere and Co., better known as John Deere, is one of the most iconic U.S ...A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.3. Johnson & Johnson. There’s arguably no better bellwether in the healthcare sector than Johnson & Johnson, which is the biggest life sciences company in the world. J&J’s products include ...Biolase Stock Forecast, BIOL stock price prediction. Price target in 14 days: 1.310 USD. The best long-term & short-term Biolase share price prognosis for 2023, 2024, 2025, …

As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Jul 26, 2023 · COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's stockholders granted the Board of Directors the discretion to effect a ... TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comInstagram:https://instagram. world war 3 newsstock tnahow to check if its real goldvegbx Nov 14, 2023 · Target values for the price of one BIOLASE share for Dec 2023. The weighted average target price per BIOLASE share in Dec 2023 is: 1.25. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.163% volatility is expected. Pessimistic target level: 1.08. Optimistic target level: 1.39. Customizable Real Time Market Alerts. Stock forecast As of 2022 April 22 Friday current price of BIOL stock is 03047 and our data indicates that the asset price has been in a downtrend for the. BIOLASE Stock Forecast 06-15-2022. BIOL stock forecast and price target. How to buy Biolase. penny picksshould i buy disney stock BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 17, 2023 · BIOLASE (NASDAQ:BIOL) has a market capitalization of $3.32 million and generates $39.19 million in revenue each year. The medical technology company earns $-16,160,000.00 in net income (profit) each year or ($3.57) on an earnings per share basis.View real-time stock prices and stock quotes for a full financial overview. ... T2 Biosystems Shares Plummet 47% on 3Q Revenue Outlook Oct. 13, 2023 at 10:54 a.m. ET ... how much is a 1979 susan b anthony worth Oct 26, 2021 · For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72. The average BIOLASE stock forecast 2031 represents a 66.26% increase from the last price of $1.14999997615814. For BIOLASE stock forecast for 2033 (10 year ... Find the latest Precision BioSciences, Inc. (DTIL) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.34% of the time in the same period.